Practical examples of advanced practice provider–led initiatives that improve safety, symptom management, and patient ...
Leopold, MD, explains how evidence-based integrative therapies like acupuncture and nutrition improve oncology patient ...
Emese Zsiros, MD, PhD, FACOG, discusses managing paclitaxel toxicity and the role of pembrolizumab maintenance in treating platinum-resistant ovarian cancer.
The FDA has approved Optune Pax, a wearable medical device that delivers Tumor Treating Fields (TTFields), for the treatment of adult patients with locally advanced pancreatic cancer (LA-PAC) ...
RMAT status for KB707 enables expedited development with enhanced FDA engagement, supported by early KYANITE-1 activity and durability in heavily pretreated advanced/metastatic NSCLC. LungTIME-C01 ...
In a clip from the latest Onc Nurse on Call episode, social worker Kelly Grosklags explains that emotions strengthen the connection between patient and clinician in oncology.
Eligibility requires progression within 6 months of last platinum and PD‑L1 CPS ≥1 by 22C3 pharmDx, after 1–2 prior systemic regimens. KEYNOTE‑B96 randomized 1:1 to pembrolizumab or placebo with ...
Ron Panarotti | Authors | Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient-centered cancer care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results